menu

KOL Knockout™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease Round 1

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

KOL Knockout™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease Round 1

1.25 credits
75 minutes

CME/CE Broadcast Replay

ReachMD Healthcare Image
Restart
Resume
Choose a format
Take Post-TestSkip straight to the post-test if you have already participated in this activity
Media formats available:
1.25 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    This fun and exciting game show-style CME program now comes to endocrinology and features key opinion leaders (KOLs) as contestants. Host Malini Gupta, MD, ECNU, FACE, will present cases to Alireza Falahati, MD, FACE; Anupam Kotwal, MD, MSc, FACE, FRCP (Edin); and Rokshana R. Thanadar, MD, who will battle it out to be crowned winner and move on to round 2!

  • Disclosure of Conflicts of Interest

    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

    The following faculty/staff members have the following financial relationships with ineligible companies.

    Host:
    Malini Gupta, MD, ECNU, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Creative Consultant. Speaker's Bureau: IBSA and Horizon. Owner/Employee: G2Endo/Consolidated Medical Practices of Memphis.

    Faculty:
    Alireza Falahati, MD, FACE, has had no financial relationships with ineligible companies.

    Anupam Kotwal, MD, MSc, FACE, FRCP (Edin)  has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon.

    Rokshana R. Thanadar, MD, has no financial relationships or affiliations with ineligible companies.

    The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Diagnose thyroid eye disease (TED) based on clinical examination and appropriate testing, to enable assessment of disease activity, severity, and impact on quality of life
    • Appraise the risk-benefit profile of medical and biological therapies for TED
    • Devise individualized treatment plans for patients with varying degrees of TED activity and severity that prevent disease progression
    • Establish referral and comanagement protocols that ensure patient access to specialized and collaborative care
  • Target Audience

    This certified continuing education activity is designed for endocrinologists and advanced practice providers involved in the care of patients with thyroid eye disease.

  • Accreditation and Credit Designation Statements

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an unrestricted educational grant from Horizon Therapeutics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education or Horizon Therapeutics. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Evolve Medical Education or Horizon Therapeutics you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    This fun and exciting game show-style CME program now comes to endocrinology and features key opinion leaders (KOLs) as contestants. Host Malini Gupta, MD, ECNU, FACE, will present cases to Alireza Falahati, MD, FACE; Anupam Kotwal, MD, MSc, FACE, FRCP (Edin); and Rokshana R. Thanadar, MD, who will battle it out to be crowned winner and move on to round 2!

  • Disclosure of Conflicts of Interest

    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

    The following faculty/staff members have the following financial relationships with ineligible companies.

    Host:
    Malini Gupta, MD, ECNU, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Creative Consultant. Speaker's Bureau: IBSA and Horizon. Owner/Employee: G2Endo/Consolidated Medical Practices of Memphis.

    Faculty:
    Alireza Falahati, MD, FACE, has had no financial relationships with ineligible companies.

    Anupam Kotwal, MD, MSc, FACE, FRCP (Edin)  has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon.

    Rokshana R. Thanadar, MD, has no financial relationships or affiliations with ineligible companies.

    The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Diagnose thyroid eye disease (TED) based on clinical examination and appropriate testing, to enable assessment of disease activity, severity, and impact on quality of life
    • Appraise the risk-benefit profile of medical and biological therapies for TED
    • Devise individualized treatment plans for patients with varying degrees of TED activity and severity that prevent disease progression
    • Establish referral and comanagement protocols that ensure patient access to specialized and collaborative care
  • Target Audience

    This certified continuing education activity is designed for endocrinologists and advanced practice providers involved in the care of patients with thyroid eye disease.

  • Accreditation and Credit Designation Statements

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an unrestricted educational grant from Horizon Therapeutics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education or Horizon Therapeutics. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Evolve Medical Education or Horizon Therapeutics you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule14 Apr 2024